Key Points
- Charles Jobson, a major shareholder, bought 10,000 shares of The Joint Corp. (NASDAQ:JYNT) on Nov. 21 at $8.50 per share for $85,000, increasing his direct holdings to 1,599,946 shares (a 0.63% ownership rise) as disclosed in an SEC filing.
- Joint trades around $8.49–$8.50 with a $126.2M market cap and a 1‑year range of $7.50–$13.47; it reported a quarterly EPS of $0.02 beating estimates but still has a negative net margin, and analysts have a consensus Hold rating with an average target of $17.00.
The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson acquired 10,000 shares of the business's stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $8.50 per share, for a total transaction of $85,000.00. Following the completion of the transaction, the insider directly owned 1,599,946 shares of the company's stock, valued at $13,599,541. This trade represents a 0.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Joint Price Performance
Shares of NASDAQ JYNT opened at $8.49 on Wednesday. The Joint Corp. has a 1-year low of $7.50 and a 1-year high of $13.47. The company has a market capitalization of $126.21 million, a price-to-earnings ratio of -25.73 and a beta of 1.48. The business has a 50-day moving average of $8.67 and a 200-day moving average of $10.17.
Joint (NASDAQ:JYNT - Get Free Report) last released its quarterly earnings results on Friday, November 7th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The firm had revenue of $13.38 million for the quarter, compared to analyst estimates of $13.36 million. Joint had a positive return on equity of 0.60% and a negative net margin of 7.02%. Research analysts expect that The Joint Corp. will post 0.11 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on JYNT shares. Weiss Ratings restated a "sell (e+)" rating on shares of Joint in a research note on Wednesday, October 8th. B. Riley lowered Joint from a "buy" rating to a "hold" rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $17.00.
Get Our Latest Analysis on Joint
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets increased its holdings in shares of Joint by 104.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company's stock valued at $28,000 after acquiring an additional 1,501 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Joint by 25.9% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company's stock worth $95,000 after purchasing an additional 1,698 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Joint by 32.3% in the second quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company's stock worth $86,000 after purchasing an additional 1,810 shares during the period. Verus Capital Partners LLC increased its stake in Joint by 1.7% during the third quarter. Verus Capital Partners LLC now owns 113,426 shares of the company's stock valued at $1,082,000 after purchasing an additional 1,947 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in Joint by 5,141.9% during the second quarter. Nisa Investment Advisors LLC now owns 2,254 shares of the company's stock valued at $26,000 after purchasing an additional 2,211 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company's stock.
Joint Company Profile
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
